Clinical trials update from the American College of Cardiology Meeting 2011: STICH, NorthStar, TARGET, and EVEREST II

European Journal of Heart Failure

Volumn 13, Issue 7, 2011, Pages 805-808

  Cleland, John G F ^a   Coletta, Alison P ^a   Freemantle, Nick ^b   Clark, Andrew L ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Heart failure; Randomized controlled trials

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CLINICAL TRIAL (TOPIC); CONFERENCE PAPER; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FOLLOW UP; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HUMAN; META ANALYSIS (TOPIC); MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTOLIC HEART FAILURE; TREATMENT OUTCOME;

CARDIOLOGY; CLINICAL TRIALS AS TOPIC; HEART FAILURE; HUMANS; SOCIETIES, MEDICAL; UNITED STATES;

EID: 79960030208     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfr077     Document Type: Conference Paper

References (16)

1. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39: 1151-1158. (Pubitemid 34267418)
2. Passamani E, Davis KB, Gillespie MJ, Killip T. A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. New Engl J Med 1985;312:1665-1671. (Pubitemid 15068573)
3. Cleland JGF, Calvert M, Freemantle N, Arrow Y, Ball SG, Bonser RS, Chattopadhyay S, Norell MS, Pennell DJ, Senior R. The heart failure revascularisation trail (HEART). Eur J Heart Fail 2011;13:227-233.
4. Cleland JGF, Freemantle N. Revascularisation for patients with heart failure. Inconsistencies between theory and practice. Eur J Heart Fail 2011;13:694-697.
5. Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G, Gradinac S, Abraham WT, Yii M, Prabhakaran D, Szwed H, Ferrazzi P, Petrie MC, O'Connor CM, Panchavinnin P, She L, Bonow RO, Rankin GR, Jones RH, Rouleau JL, for the STICH Investigators. Coronary artery bypass surgery in patients with left ventricular dysfunction. N Eng J Med 2011;364:1607-1616.
6. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-989.
7. Gustafsson F, Schou M, Videback L, Dridi N, Ryde H, Handberg J, Hildebrandt PR. Incidence and predictors of hospitalization or death in patients managed in multidisciplinary heart failure clinics. Eur J Heart Fail 2009;11:413-419.
8. Schou M, Gustafsson F, Videbaek L, Markenvard J, Ulriksen H, Ryde H, Jensen JC, Nielsen T, Knudson AS, Tuxen CD, Handberg J, Sorensen PJ, Espersen G, Lind-Rasmussen S, Keller N, Egstrup K, Nielsen OW, Abdulla J, Nyvad O, Toft J, Hildebrand PR. Design and methodology of the NorthStar study: NT-proBNP stratified follow-up in outpatient heart failure clinics- a randomized Danish multicentre study. Am Heart J 2008;156:649-655.
9. Cleland JGF, McDonagh T, Rigby AS, Yassin A, Whittaker T, Dargie HJ, on behalf of the National Heart Failure Audit Team for England and Wales. The national heart failure audit for England and Wales 2008-2009. Heart 2011;97: 876-886.
10. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the cardiac resynchronisation-heart failure (CARE-HF) trial extension phase]. Eur Heart J 2006;27:1928-1932. (Pubitemid 44297365)
11. Van Veldhuisen DJ, Maas AH, Priori SG, Stolt P, van Gelder IC, Dickstein K, Swedberg K. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur J Heart Fail 2009;11: 1143-1151.
12. Cleland JGF, Tageldien A, Buga L, Wong K, Gorcsan J. Should we be trying to define responders to cardiac resynchronisation therapy? JACC: Cardiovasc Imaging 2010;3:541-549.
13. Cleland JGF, Tavazzi L, Daubert JC, Tageldien A, Freemantle N. Cardiac resynchronisation therapy. Are modern myths preventing appropriate use? J Am Coll Cardiol 2009;53:608-611.
14. Cleland J, Freemantle N, Ghio S, Fruhwald F, Shankar A, Marijanowski M, Verboven Y, Tavazzi L. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response. A report from the CARE-HF trial. J Am Coll Cardiol 2008;52:438-445. (Pubitemid 352040815)
15. Cleland JGF, Coletta AP, Buga L, Ahmed D, Clark AL. Clinical trials update from the American College of Cardiology Meeting 2010: DOSE, ASPIRE, CONNECT, STICH, STOP-AF, CABANA, RACE II, EVEREST II, ACCORD and NAVIGATOR. Eur J Heart Fail 2010;12:623-629.
16. Feldman T, Foster E, Glower DG, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E, Loghin C, Trento A, Skipper ER, Fudge T, Letsou GV, Massaro JM, Mauri L, for the EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Eng J Med 2011;364:1395-1406.